Compare VYGR & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VYGR | AIRS |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.0M | 166.3M |
| IPO Year | 2015 | 2021 |
| Metric | VYGR | AIRS |
|---|---|---|
| Price | $3.79 | $1.73 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $17.00 | $2.50 |
| AVG Volume (30 Days) | 527.4K | ★ 859.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $10,135,000.00 | ★ $180,350,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $71.77 | $2.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.65 | $1.53 |
| 52 Week High | $5.55 | $12.00 |
| Indicator | VYGR | AIRS |
|---|---|---|
| Relative Strength Index (RSI) | 47.48 | 33.72 |
| Support Level | $2.79 | N/A |
| Resistance Level | $3.73 | $3.29 |
| Average True Range (ATR) | 0.21 | 0.21 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 54.65 | 8.93 |
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.